Central Surgical Association| Volume 82, ISSUE 4, P438-442, October 1977

Augmented gastric inhibitory polypeptide response to intraduodenal glucose by exogenous gastrin and cholecystokinin

      This paper is only available as a PDF. To read, Please Download here.


      Five awake dogs with Mann-Bollman fistulas each underwent six daily studies in which 50 ml of 20% glucose was infused intraduodenally (ID) over a period of 10 minutes. In five of six studies, either gastrin, pentagastrin, cholecystokinin, secretin, or glucagon was infused intravenously (IV) for 30 minutes before and 120 minutes after ID administered glucose. Venous blood samples at 15-minute intervals were assayed for immunoreactive gastric inhibitory peptide (GIP). IV administered gastrin, pentagastrin, cholecystokinin, secretin, and glucagon had no effect on fasting immunoreactive GIP (iGIP). Compared to fasting, iGIP was significantly (p < 0.05) increased at 15, 30, and 45 minutes for all treatment groups. Compared to ID administered glucose alone, the GIP response following either IV gastrin plus ID glucose, IV pentagastrin plus ID glucose, or IV cholecystokinin plus ID glucose was significantly greater (p < 0.05) at 5 and 15 minutes. This study demonstrates augmentation of glucose-stimulated GIP by the structurally similar peptides; gastrin, pentagastrin, and cholecystokinin, suggesting a physiological role for endogenous gastrin and cholecystokinin in modulating the GIP response to glucose.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Brown J.C.
        • Dryburgh J.R.
        A gastric inhibitory polypeptide. II. The complete amino acid sequence.
        Can J Biochem. 1971; 49: 867
        • Brown J.C.
        • Pederson R.A.
        • Jorpes J.E.
        • et al.
        Preparation of highly active enterogastrone.
        Can J Physiol Pharmacol. 1969; 47: 113
        • Cataland S.
        • Crockett S.E.
        • Brown J.C.
        • et al.
        Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man.
        J Clin Endocrinol Metab. 1974; 39: 223
        • Desbuquois B.
        • Aurbach G.D.
        Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassays.
        J Clin Endocrinol. 1971; 33: 732
        • Dupre J.
        • Ross S.A.
        • Watson D.
        • et al.
        Stimulation of insulin secretion by gastric inhibitory polypeptide in man.
        J Clin Endocrinol Metab. 1973; 37: 826
        • Falko J.M.
        • Crockett S.E.
        • Cataland S.
        • et al.
        Gastric inhibitory polypeptide (GIP) stimulated by fat ingestion in man.
        J Clin Endocrinol Metab. 1975; 41: 260
        • Hunter W.M.
        • Greenwood F.C.
        Preparation of iodine-131 labeled human growth hormone of high specific activity.
        Nature. 1962; 194: 495
        • Kuzio M.
        • Dryburgh J.R.
        • Malloy K.M.
        • et al.
        Radioimmunoassay for gastric inhibitory polypeptide.
        Gastroenterology. 1974; 66: 357
        • Leithold L.
        The calculus with analytic geometry.
        in: Harper and Row Publishers, New York1972: 544
        • O'Dorisio T.M.
        • Cataland S.
        • Stevenson M.
        • et al.
        Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides.
        Dig Dis. 1976; 21: 761
        • Pederson R.A.
        • Brown J.C.
        Inhibition of histamine, pentagastrin, and insulin-stimulated canine gastric secretion by pure gastric inhibitory polypeptide.
        Gastroenterology. 1972; 62: 393
        • Polak J.M.
        • Bloom S.R.
        • Kuzio M.
        • et al.
        Cellular localization of gastric inhibitory polypeptide in the duodenum and jejunum.
        Gut. 1973; 14: 284
      1. Sirinek, K. R.: Unpublished data

        • Sirinek K.R.
        • Crockett S.E.
        • Mazzaferri E.L.
        • et al.
        Release of gastric inhibitory polypeptide: Comparison of glucose and fat as stimuli.
        in: Surg Forum. 25. 1974: 361
      2. Tetirick, C. E.: Unpublished data